STANDBY EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • October 19th, 2022 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 19th, 2022 Company Industry JurisdictionTHIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of October 13, 2022 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “Investor”), and KIROMIC BIOPHARMA, INC., a company incorporated under the laws of the State of Delaware (the “Company”).